Skip to main content
OpenTrials

Clinical trial condition

Arthritis, Rheumatoid

Explore clinical trials studying Arthritis, Rheumatoid. Study availability and eligibility vary by location and protocol.

2,458 public trials 233 recruiting studies
Refine in advanced search Browse all conditions

Arthritis, Rheumatoid trial results

Completed

Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis

NCT01262118

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Pfizer Investigational Site Anniston, Alabama, United States
  • Pfizer Investigational Site Anniston, Alabama, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View Trial Details
Completed

A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis

NCT00814307

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Pfizer Investigational Site Gilbert, Arizona, United States
  • Pfizer Investigational Site Tucson, Arizona, United States
  • Pfizer Investigational Site Hot Springs, Arkansas, United States
  • Pfizer Investigational Site Jacksonville, Florida, United States
View all 95 locations
View Trial Details
Completed

Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis

NCT00413660

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Pfizer Investigational Site Gilbert, Arizona, United States
  • Pfizer Investigational Site Hot Springs, Arkansas, United States
  • Pfizer Investigational Site Upland, California, United States
  • Pfizer Investigational Site Denver, Colorado, United States
View all 82 locations
View Trial Details
Completed

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

NCT00853385

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Pfizer Investigational Site Gilbert, Arizona, United States
  • Pfizer Investigational Site Glendale, Arizona, United States
  • Pfizer Investigational Site Mesa, Arizona, United States
  • Pfizer Investigational Site Paradise Valley, Arizona, United States
View all 125 locations
View Trial Details
Completed

A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications

NCT00856544

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Pfizer Investigational Site Huntsville, Alabama, United States
  • Pfizer Investigational Site Jonesboro, Arkansas, United States
  • Pfizer Investigational Site Palo Alto, California, United States
  • Pfizer Investigational Site Stanford, California, United States
View all 133 locations
View Trial Details
Completed

A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis

NCT00976599

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site La Jolla, California, United States
View all 15 locations
View Trial Details
Completed

A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis

NCT00550446

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Pfizer Investigational Site Mesa, Arizona, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Northridge, California, United States
  • Pfizer Investigational Site Palo Alto, California, United States
View all 63 locations
View Trial Details

Related conditions